- Tytuł:
- Open-label phase I/II clinical trial of SARS-CoV-2 receptor binding domain-tetanus toxoid conjugate vaccine (FINLAY-FR-2) in combination with receptor binding domain-protein vaccine (FINLAY-FR-1A) in children
- Autorzy:
- Źródło:
- In International Journal of Infectious Diseases January 2023 126:164-173
Czasopismo naukowe